Hung Yen: 5.2 thousand people will participate in the clinical trial of the Nanocovax vaccine at phase 3.

On May 18, at the Headquarter of the Provincial People's Committee, the delegation of the Military Medical University and Nanogen Pharmaceutical Biotechnology Joint Stock Company led by Lieutenant General Prof. Dr. Do Quyet, Director of the Military Medical University worked with the province on conducting clinical research at phase 3, evaluating the safety, immunogenicity and protective efficacy of the Nanocovax vaccine in Hung Yen province. The delegation was received by and worked with Mr. Tr...

On May 18, at the Headquarter of the Provincial People's Committee, the delegation of the Military Medical University and Nanogen Pharmaceutical Biotechnology Joint Stock Company led by Lieutenant General Prof. Dr. Do Quyet, Director of the Military Medical University worked with the province on conducting clinical research at phase 3, evaluating the safety, immunogenicity and protective efficacy of the Nanocovax vaccine in Hung Yen province. The delegation was received by and worked with Mr. Tr...

Delegates at the working session

At the working session, the representative of the Military Medical University introduced the research and production process of the Nanocovax vaccine. NanoCovax vaccine, which is researched by the Military Medical University and manafactured by Nanogen Pharmaceutical Biotechnology Joint Stock Company, has so far completed the clinical trial at phase 2. The clinical and preclinical research results show that the vaccine is safe and immunogenic. In the near future, the vaccine will be conducted in clinical trial at phase 3. The purpose of the delegation to work with the province is to ask Hung Yen province to approve the clinical trial of the Nanocovax vaccine at phase 3 in the province with the number of 5.2 thousand people. The criteria for selecting testing subjects are people from the age of 18 at the time of screening and the ones at high risk of Covid-19 infection… Hung Yen is a locality, which is selected to participate in clinical research on the basis of the medical staff's capacity and experience in vaccination and despite being the epidemic area, the infected number is small.

Talking to the delegation, Chairman of the Provincial People's Committee Tran Quoc Van quickly informed the delegation about the situation of the Covid-19 epidemic in the area, the epidemic prevention and control, including the measures to vaccinate against the Covid-19; at the same time, he expressed his support for conducting clinical trials in the province. He proposed the subjects, who are tested this time are in crowded places such as markets, apartment buildings, schools, and businesses. He hoped that the unit would soon mass-produce the Nanocovax vaccine to inject people, contributing to repelling the Covid-19 epidemic and affirming Vietnam's ability to research and produce vaccine against the Covid-19.

 


Các tin khác

Tin mới nhất

Xem nhiều nhất

Fanpage

Bình chọn

Đánh giá của bạn về Trang Thông tin điện tử tổng hợp Đối ngoại Hưng Yên
2 người đã bình chọn

Thống kê truy cập

  • Hôm nay:
  • Hôm qua:
  • Tuần này:
  • Tháng này:
  • Năm nay: